Literature DB >> 8142224

Endothelin-1 in children with chronic renal failure.

I Blazy1, M Déchaux, M Charbit, D Brocart, J C Souberbielle, M F Gagnadoux, F Guillot, C Sachs.   

Abstract

Endothelin-1 (ET-1) was measured after extraction from plasma of normal adults (5.9 +/- 1.9 pg/ml, n = 22), normal children (7.1 +/- 1.86 pg/ml, n = 29), non-haemodialysed children with chronic renal failure (CRF) (11.1 +/- 1.8 pg/ml), n = 10), renal graft recipients (9.5 +/- 3.4 pg/ml, n = 37), haemodialysed children 24 h after a haemodialysis session (20.02 +/- 10.9 pg/ml, n = 26) and haemodialysed children before and after a haemodialysis session (15.31 +/- 10.6 and 13.8 +/- 8.5 respectively, n = 14). A sensitive and specific radioimmunoassay was used. ET-1 was significantly higher in non-haemodialysed CRF children and in renal graft recipients than in normal children (P < 0.001 and P < 0.01, respectively) and significantly higher in haemodialysed children when compared with normal children, non-haemodialysed CRF children and renal graft recipients (P < 0.001). ET-1 concentrations were similar in normal children and normal adults. ET-1 was inversely correlated with glomerular filtration rate in non-haemodialysed CRF children (r = -0.39, P < 0.01) and positively correlated with extracellular volume in haemodialysed children (r = 0.435, P < 0.03). After haemodialysis, ET-1 increased in 6 and decreased in 8 of the 14 children studied before and after a haemodialysis session.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142224     DOI: 10.1007/bf00868258

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells.

Authors:  M Yoshizumi; H Kurihara; T Sugiyama; F Takaku; M Yanagisawa; T Masaki; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

2.  Plasma endothelin levels in healthy children: high values in early infancy.

Authors:  M Yoshibayashi; K Nishioka; K Nakao; Y Saito; S Temma; M Matsumura; T Ueda; G Shirakami; H Imura; H Mikawa
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  Postural change and volume expansion affect plasma endothelin levels.

Authors:  M Shichiri; Y Hirata; K Ando; K Kanno; T Emori; K Ohta; F Marumo
Journal:  JAMA       Date:  1990-02-02       Impact factor: 56.272

4.  Plasma concentrations of endothelin-1 and endothelin-3 are altered differently in various pathophysiological conditions in humans.

Authors:  T Miyauchi; Y Sugishita; I Yamaguchi; R Ajisaka; T Tomizawa; M Onizuka; M Matsuda; I Kono; M Yanagisawa; K Goto
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

Review 5.  Endothelin: an important factor in acute renal failure?

Authors:  J D Firth; P J Ratcliffe; A E Raine; J G Ledingham
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

6.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Endothelin in renal failure.

Authors:  A N Warrens; M J Cassidy; K Takahashi; M A Ghatei; S R Bloom
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

8.  Plasma endothelin concentration: relation with vascular resistance and comparison before and after balloon dilatation procedures.

Authors:  T Ino; M Ohkubo; S Shimazaki; K Akimoto; K Nishimoto; M Iwahara; K Yabuta; Y Hosoda
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

9.  Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide.

Authors:  S Gasic; O F Wagner; H Vierhapper; P Nowotny; W Waldhäusl
Journal:  J Cardiovasc Pharmacol       Date:  1992-02       Impact factor: 3.105

10.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

View more
  1 in total

Review 1.  Evaluation and treatment of chronic renal failure.

Authors:  A Moudgil; A Bagga
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.